Experimental studies in humans

Publications:

 

Wilson JA, Johnston D, Penston J, Wormsley KG.

Gastric inhibitory effects of CM57755. A new histamine H2 receptor antagonist.

European Journal of  Clinical Pharmacology 1986;30(1):33-6.

 

Penston J, Johnston DA, Wilson JA, Wormsley KG.

Inhibition of nocturnal gastric secretion by trimoprostil, a synthetic prostanoid.

Current Medical Research and Opinion 1986;10(3):145-9.

 

Penston JG, Johnston DA, Wormsley KG.

Trimoprostil decreases acid disappearance from the human stomach.

Current Medical Research and Opinion 1986;10(5):308-12.

 

Wilson JA, Johnston DA, Penston J, Wormsley KG.

Inhibition of human gastric secretion by ICI 162,846--a new histamine H2-receptor antagonist.

British Journal of Clinical Pharmacology 1986 Jun;21(6):685-9.

 

Penston JG, Johnston DA, Wormsley KG.

The effects of rioprostil on gastric emptying and intragastric acidity.

Hepatogastroenterology. 1986 Jun;33(3):120-2.

 

Hamilton I, Boyd EJ, Jacyna MR, Penston JG, Soutar JS, Bouchier IA.

Pancreatic function and enzyme synthesis rates in mild chronic pancreatitis.

Scandinavian Journal of Gastroenterology 1986 Jun;21(5):542-6

 

Johnston DA, Jankowski J, Penston JG, Wormsley KG.

Inhibition of nocturnal gastric secretion is not necessary for ulcer healing.

European Journal of Gastroenterology and Hepatology 1989; 1; 187-191.

 

Corbett ME, Boyd EJ, Penston JG, Wormsley KG, Watt PW, Rennie MJ.

Pentagastrin increases pepsin secretion without increasing its fractional synthetic rate.

American Journal of Physiology 1995 Sep;269(3 Pt 1):E418-25.